CAS 1197-18-8 Tranexamic Acid
- FOB Price:Get Latest Price >
- Min.Order:10 g(s)
- Production Capacity:50000kg
- Payment Terms:T/T , Western Union , Money Gram
- Favorite
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
Hangzhou Fuluo Biological Technology Co.Ltd
We are professional supplier of Steroid Hormones,Injectable Steroids,Peptides,SARMS,Weight loss powder,Sex hormone,Anti estrogen,Local anesthetic.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
CAS 1197-18-8 Tranexamic Acid
Product Name: Tranexamic Acid,amstat,tranexa,transamic acid
CAS No: 1197-18-8
EINECS No: 214-818-2
Molecular Formula: C8H15NO2
Molecular Weight: 157.21
Purity:99%
Melting point: >300 °C(lit.)
Appearance: white powder
Grade:Pharmaceutical Grade
Application: Mainly used for Whitening freckle,Hemostasis
Tranexamic acid (TXA) is used to treat or prevent excessive blood loss from trauma, surgery, and in various medical conditions including hemophilia and heavy menstrual bleeding.It comes in oral and intravenous forms.
Tranexamic acid is frequently used following major trauma.Tranexamic acid is used to prevent and treat blood loss in a variety of situations, such as dental procedures for hemophiliacs, heavy menstrual bleeding, and surgeries with high risk of blood loss.
Trauma:Tranexamic acid has been found to decrease the risk of death in people who have significant bleeding due to trauma.[7] However, its benefit only appears to be within the first three hours.
Heavy menstrual bleeding:Tranexamic acid is used treat heavy menstrual bleeding.When taken by mouth it is both safely and effectively treated regularly occurring heavy menstrual bleeding.Another study demonstrated that the dose does not need to be adjusted in people who are between ages 12 and 16.
Surgery:Tranexamic acid is used in orthopedic surgery to reduce blood loss, to the extent of reducing or altogether abolishing the need for perioperative blood collection. It is of proven value in clearing the field of surgery and reducing blood loss when given before or after surgery. Drain and number of transfusions are reduced. However, the hidden blood loss is not reduced. Still, it is becoming an important tool in the anaesthetist's arsenal. It is commonly used in joint replacement surgery.
Use of tranexamic acid in surgical corrections of craniosynostosis in children reduces the need for blood transfusions.
Tranexamic acid is commonly used in cardiac surgery, both with and without cardiopulmonary bypass. It replaces aprotinin.